explore
Previous article:
BioMarin wins approval for gene therapy to treat hemophilia A
Next article: Tocagen's brain cancer gene therapy trial continues. Investors worry
Next article: Tocagen's brain cancer gene therapy trial continues. Investors worry
leisure time
leisure time
-
Ending racial health disparities hinges on penalties, political will
2025-09-30 19:30 -
Ending racial health disparities hinges on penalties, political will
2025-09-30 18:48 -
Hospitals struggle to profit from CAR
2025-09-30 18:43 -
Why Sanofi got shellacked over its spinoff
2025-09-30 18:25 -
Readout Newsletter: What happened with Sarepta's Duchenne data
2025-09-30 18:19 -
Meta's Zuckerberg and Chan on track to put $50 billion into science
2025-09-30 17:24